Fujirebio – Socially Bharat

socially bharat
December 23, 2024
3 Mins Read

Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases

TOKYO, Japan: Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa; Head Office: Minato-ku, Tokyo), a wholly-owned subsidiary of H.U. Group

130 Views
0 Comments

socially bharat
September 25, 2024
3 Mins Read

Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/ß-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

TOKYO, Japan & MALVERN, Pa., United States: —Expected to Be First Commercially-Available Blood-Based In-Vitro Diagnostic for Patients Being Assessed for

159 Views
0 Comments

Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.

Quick Links

Contact Us

Stay Updated

Share Your Message!